Administration, MetronomicAngiogenesis InhibitorsAntimetabolites, Antineoplastic
Dr. Mollie Rene Deshazo, MD
NPI1487603841PAC ID8123030558
- Medicare services, 2024
- 3,945
- Medicare patients, 2024
- 150
- Part D claims, 2024
- 1,512
- Publications
- 9
- Clinical trials
- 1
- Practice address
- 619 19th S St, Birmingham, AL 35211
- Practice phone
- Call (205) 731-9770
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University of Alabama Birmingham Hospital
Birmingham, Alabama
Find Dr. Deshazo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mollie Rene Deshazo is a hematologist and oncologist in Birmingham, Alabama
Dr. Deshazo practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.
Dr. Deshazo's NPI, 1487603841, was assigned on May 10, 2006. Dr. Deshazo graduated from University of Alabama School of Medicine in 2000. Dr. Deshazo holds Alabama license 24415.
NPI and contact details
- NPI
- 1487603841NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8123030558
- NPI enumeration date
- May 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (205) 731-9770
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mollie Rene Deshazo practices at University of Alabama Birmingham Hospital in Birmingham, Alabama
Dr. Deshazo's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.
- University of Alabama Birmingham Hospital619 19th S St, Birmingham, AL 35211 · Jefferson CountyPhone(205) 731-9770
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mollie Rene Deshazo is affiliated with 2 sites of care and 2 medical groups
Dr. Deshazo's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Deshazo is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Deshazo to 1 more medical group, named with a free account.
University of Alabama Birmingham HospitalPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mollie Rene Deshazo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deshazo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Alabama Birmingham Hospital | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Deshazo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mollie Rene Deshazo is one of 169 hematologists and oncologists in Alabama
Hematology and oncology is Dr. Deshazo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Deshazo is licensed in Alabama.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
Hematologists and oncologists near Dr. Deshazo
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mollie Rene Deshazo billed Medicare for 3,945 services in 2024
CMS data shows 3,945 Medicare services from Dr. Deshazo across 18 procedure codes in 2024, for 150 Medicare patients. Medicare paid $78,838 for them.
Medicare services, 20243,945
Medicare patients150
Paid by Medicare$78,838
Procedure codes18
Dr. Deshazo's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 2,5362024: 1,98622%
- Lab and pathology
- 2023: 1,0022024: 72727%
- Office and hospital visits
- 2023: 3852024: 54241%
- Surgery
- 2023: 4652024: 4445%
- Drugs given in the office
- 2023: 2,2142024: 12694%
- Tests and treatments
- 2023: 1302024: 8138%
- Imaging
- 2023: 542024: 3928%
Where Dr. Deshazo's Medicare services took place, 2024
- In an office3,91799%
- In a facility281%
Dr. Deshazo compared with the Alabama median for hematologists and oncologists, 2024
- Dr. Deshazo
- Alabama median
- Medicare services
- 3,945vs 1,2243.2 times
- Medicare patients
- 150vs 28247% below
- Part D claims
- 1,270vs 84650% above
Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.
Dr. Deshazo's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Deshazo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Deshazo and other hematologists and oncologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mollie Rene Deshazo treated 150 Medicare patients in 2024, average age 77
CMS counts 150 Medicare patients who saw Dr. Deshazo in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Deshazo's median patient age at 71, with 19% women.
Medicare patients, 2024150
Average age77
Average risk score2.61
Dr. Deshazo's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Deshazo's Medicare patients by sex, 2024
- Women1510%
- Men13590%
Chronic conditions among Dr. Deshazo's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis57%
- Diabetes43%
- Ischemic heart disease42%
- Chronic kidney disease33%
- Atrial fibrillation24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Deshazo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women19%
- Men80%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mollie Rene Deshazo wrote 1,512 Medicare Part D claims in 2024
In 2024, Dr. Deshazo wrote 1,512 Medicare Part D claims for 203 patients. 56% of them were for generic drugs. CMS names the drug for 1,270 of them, across 22 drugs with 11 or more claims each, at $5,621,149 in total drug cost. In 2023, CMS named 1,056 claims across 27 drugs.
Part D claims, 20241,512
Drugs named by CMS22
Total drug cost$5.6M
Part D patients203
Dr. Deshazo's Part D claims by kind of drug, 2024
- Generic854 claims56%
- Brand-name658 claims44%
Dr. Deshazo's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Deshazo's Part D claims, 2024
- Opioids13%191 of 1,512 claims
- Antibiotics2%23 of 1,512 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0562024: 1,27020%
Drugs named by CMS: 22 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mollie Rene Deshazo scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Deshazo for performance year 2024, reported as part of a group. Dr. Deshazo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deshazo as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Deshazo's MIPS scores, performance year 2024
- 83of 100Final score
- 68.8of 100Quality
- 89of 100Promoting Interoperability
- 40of 100Improvement Activities
- 84of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Deshazo by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mollie Rene Deshazo has 9 publications on record
Dmand AI links 9 papers to Dr. Deshazo, published from 2012 to 2021. The most frequent topics are Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Dr. Deshazo's most frequent co-authors are Apar Kishor Prakashrao Ganti, MD, Graeme B. Bolger, MD and Martine Extermann, MD.
Papers9
Years published2012 to 2021
Dr. Deshazo's papers by year, 2012 to 2021
Topics Dr. Deshazo writes about most
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Dr. Deshazo's most frequent co-authors
- Apar Kishor Prakashrao Ganti, MD3 shared papers
- Graeme B. Bolger, MD2 shared papers
- Martine Extermann, MD2 shared papers
Recent publications by Dr. Deshazo
Clin Genitourin Cancer
Black or African AmericanCystectomyUrinary Bladder Neoplasms
Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellLymphatic Metastasis
See who Dr. Deshazo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Deshazo works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mollie Rene Deshazo has worked on 1 clinical trial
Dmand AI links Dr. Deshazo to 1 clinical trial. Conditions studied include Uterine Cervical Neoplasms and Uterine Cervical Diseases.
Conditions in Dr. Deshazo's trials
- Uterine Cervical Neoplasms
- Uterine Cervical Diseases
Recent clinical trials with Dr. Deshazo
Phase I Dose Escalation Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors (opens in a new tab)
CompletedPhase 1
Uterine Cervical NeoplasmsUterine Cervical DiseasesBevacizumabNintedanib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mollie Rene Deshazo received $37,835 in industry payments from 2016 to 2025
CMS Open Payments shows 230 general payments to Dr. Deshazo from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Seagen Inc. paid the most, $11,039.
General payments to Dr. Deshazo by program year, 2016 to 2025
General payments to Dr. Deshazo by kind, 2016 to 2025
$37.8Kin total
- Speaker and faculty fees$18,77850%
- Consulting fees$10,23627%
- Food and beverage$4,40212%
- Travel and lodging$3,70910%
- Education$7112%
Companies that paid Dr. Deshazo the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mollie Rene Deshazo graduated from University of Alabama School of Medicine
Dr. Deshazo graduated from University of Alabama School of Medicine in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mollie Rene Deshazo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mollie Rene Deshazo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mollie Rene Deshazo's NPI number?
Dr. Mollie Rene Deshazo's NPI number is 1487603841. It was assigned on May 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mollie Rene Deshazo?
Dr. Mollie Rene Deshazo is a hematologist and oncologist in Birmingham, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mollie Rene Deshazo practice?
Dr. Deshazo practices at 619 19th S St, Birmingham, AL 35211. Dr. Deshazo's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dmand AI also links Dr. Deshazo to 1 medical group.
What is Dr. Mollie Rene Deshazo's office phone number?
The practice phone on file for Dr. Deshazo is (205) 731-9770.
What is Dr. Mollie Rene Deshazo's medical license number?
Dr. Deshazo holds Alabama license 24415.
Which hospitals is Dr. Mollie Rene Deshazo affiliated with?
Dr. Deshazo is affiliated with UAB Hospital.
What medical group is Dr. Mollie Rene Deshazo part of?
Dr. Deshazo is linked to UAB Medicine. Dmand AI links Dr. Deshazo to 1 more medical group.
Does Dr. Mollie Rene Deshazo accept Medicare?
Yes. CMS data shows Dr. Deshazo billed Medicare for 3,945 services in 2024, and Dr. Deshazo accepts Medicare assignment.
Does Dr. Mollie Rene Deshazo offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Deshazo as offering telehealth services.
What is Dr. Mollie Rene Deshazo's MIPS score?
Dr. Deshazo's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Mollie Rene Deshazo see?
CMS counts 150 Medicare patients who saw Dr. Deshazo in 2024, with an average age of 77.
What services does Dr. Mollie Rene Deshazo bill to Medicare?
In 2024, Dr. Deshazo's most billed Medicare services were medicare temporary code (Q9967), surgery: heart and blood vessels (36415) and medicare service (G2211).
Where did Dr. Mollie Rene Deshazo go to medical school?
Dr. Deshazo graduated from University of Alabama School of Medicine in 2000.
What drugs does Dr. Mollie Rene Deshazo prescribe most?
In 2024 Medicare Part D data, Dr. Deshazo's most prescribed drugs by claims were Orgovyx, Nubeqa and Prednisone.
Has Dr. Mollie Rene Deshazo received payments from drug or device companies?
CMS Open Payments shows $37,835 in general payments to Dr. Deshazo from 32 companies from 2016 to 2025. The largest total came from Seagen Inc.
How long has Dr. Mollie Rene Deshazo been practicing?
Dr. Deshazo graduated from medical school in 2000, 26 years ago.
Does Dr. Mollie Rene Deshazo do research?
Dmand AI links 9 publications to Dr. Deshazo, published from 2012 to 2021. Dr. Deshazo has worked on 1 clinical trial.
Who does Dr. Mollie Rene Deshazo publish with?
Dr. Deshazo's most frequent co-authors are Apar Kishor Prakashrao Ganti, MD (3 shared papers), Graeme B. Bolger, MD (2 shared papers) and Martine Extermann, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card